Resource Centre
Discover a wealth of knowledge and insights from the experts at StarFish Medical. Our Resource Centre offers product development tips, reviews of new and cutting-edge technologies, and in-depth articles on regulatory updates and compliance in medical device development.
-
Over the last six decades, the use of lasers in medicine has grown rapidly. Lasers are now commonly used both as diagnostic tools and in various treatment modalities. This whitepaper is designed for readers considering, choosing, or implementing a laser-based technology in the device they are developing. It discusses the principles of operation of lasers, their useful properties, and their interactions with biological tissues, along with a non-exhaustive overview of the myriad ways in which they have been applied in medicine.
-
Eight tips to help successfully implement a POC diagnostic platform optical detection with a disposable microfluidic cartridge.
-
What is a coronavirus and why is a CoVID-19 Point of Care (POC) Diagnostic so important? Background and analysis of the vital role of POCs.
-
Monte Carlo Simulation for Biomedical Device Design: A common approach to simulate scattering is the Monte Carlo technique.
-
Biological sciences medical device breakthroughs for this decade have a solid base to build upon. Here are our top five picks for the 2020’s.
-
Translating point of care assays into a simple, low cost and easy to use microfluidic cartridge is straightforward with these six steps.
-
Dr. Katherine Elvira speaks about her work developing lab-on-a-chip (microfluidic) technologies to investigate how drugs enter human cells.
-
Developing a “lab-on-a-chip” (LOC) solution brings unique challenges and benefits. 6 tips for developing a “lab-on-a-chip” (LOC) solution.
-
The amount of total company funding to develop a Class II 510(k) cleared medical device is approximately $30 million. The development and engineering costs comprise approximately $2-5 million of this total. This estimate is built upon a meta-analysis of various references as well as our experiences in engaging with companies. Many factors influence these costs, including the need for clinical studies, regulatory pathway, and technology complexity. Refinement of these numbers requires a professional team to understand the technology, regulatory, and business opportunities.
